Lipocalin-2 induced LDHA expression promotes vascular remodelling in pulmonary hypertension

Abstract

Aerobic glycolysis is involved in the pathogenesis of pulmonary hypertension (PH). The mechanisms by which glycolysis is increased and how it contributes to pulmonary vascular remodelling are not yet fully understood. In this study, we demonstrated that elevated lipocalin-2 (LCN2) in PH significantly enhances aerobic glycolysis in human pulmonary artery smooth muscle cells (PASMCs) by up-regulating LDHA expression. Knockout of Lcn2 or having heterozygous LDHA deficiency in mice significantly inhibits the progression of hypoxic PH. Our study reveals that LCN2 stimulates LDHA expression by activating Akt-HIF-1α signalling pathway. Inhibition of Akt or HIF-1α reduces LDHA expression and proliferation of PASMCs. Both Akt and HIF-1α play critical roles in the development of PH and are suppressed in the pulmonary vessels of hypoxic PH mice lacking LCN2. These findings shed light on the LCN2-Akt-HIF1α-LDHA axis in aerobic glycolysis in PH.

References

[1] PaulinR, Michelakis ED. The metabolic theory of pulmonary arterial hypertension. Circ Res. 2014; 115(1):148-164.

[2] CulleyMK, ChanSY. Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains. J Clin Invest. 2018; 128(9):3704-3715.

[3] XuW, KoeckT, LaraAR, et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A. 2007; 104(4):1342-1347.

[4] LiM, RiddleS, ZhangH, et al. Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C-terminal binding Protein-1. Circulation. 2016; 134(15):1105-1121.

[5] ChenJ, ZhangM, LiuY, et al. Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension. J Mol Cell Biol. 2023; 14(12):mjac073.

[6] PiperB, Bogamuwa S, HossainT, et al. RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension. J Clin Invest. 2024; 134(3):e169441.

[7] MedeirosHCD, LuntSY. The Warburg effect: saturation of mitochondrial NADH shuttles triggers aerobic lactate fermentation. Mol Cell. 2022; 82(17):3119-3121.

[8] WangY, PattiGJ. The Warburg effect: a signature of mitochondrial overload. Trends Cell Biol. 2023; 33(12):1014-1020.

[9] ValvonaCJ, Fillmore HL, NunnPB, PilkingtonGJ. The regulation and function of lactate dehydrogenase a: therapeutic potential in brain tumor. Brain Pathol. 2016; 26:3-17.

[10] ZhouY, GuoY, RanM, et al. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing. Cancer Lett. 2023; 577:216425.

[11] WangX, FanW, LiN, et al. YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2. Genome Biol. 2023; 24(1):87.

[12] SethP, Csizmadia E, HedblomA, et al. Deletion of lactate dehydrogenase-a in myeloid cells triggers antitumor immunity. Cancer Res. 2017; 77(13):3632-3643.

[13] LiuJ, ZhangC, ZhangT, et al. Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer. Nat Metab. 2022; 4(12):1830-1846.

[14] JiaM, YueX, SunW, et al. ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation. Sci Adv. 2023; 9(22):eadg4993.

[15] LvY, TangW, XuY, et al. Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis. Int J Biol Sci. 2023; 19(4):1284-1298.

[16] SunW, JiaM, FengY, Cheng X. Lactate is a bridge linking glycolysis and autophagy through lactylation. Autophagy. 2023; 19(12):3240-3241.

[17] YangL, Gilbertsen A, XiaH, et al. Hypoxia enhances IPF mesenchymal progenitor cell fibrogenicity via the lactate/GPR81/HIF1α pathway. JCI Insight. 2023; 8(4):e163820.

[18] AsafS, Maqsood F, JalilJ, et al. Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials. Immunol Res. 2023; 71(3):287-313.

[19] KimKE, LeeJ, ShinHJ, et al. Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice. Hepatology. 2023; 77(3):888-901.

[20] WenX, SuB, GaoM, et al. Obesity-associated up-regulation of lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing endoplasmic reticulum stress. Cell Death Dis. 2021; 12(2):221.

[21] WuD, WangX, HanY, WangY. The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model. BMC Genomics. 2021; 22(1):892.

[22] JavaidHMA, KoE, JooEJ, et al. TNFα-induced NLRP3 inflammasome mediates adipocyte dysfunction and activates macrophages through adipocyte-derived lipocalin 2. Metabolism. 2023; 142:155527.

[23] ShiZ, YinY, LiC, et al. Lipocalin-2-induced proliferative endoplasmic reticulum stress participates in Kawasaki disease-related pulmonary arterial abnormalities. Sci China Life Sci. 2021; 64(6):1000-1012.

[24] WangG, LiuX, MengL, et al. Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to apoptosis. Int J Biol Sci. 2014; 10(7):798-806.

[25] WangG, MaN, MengL, Wei Y, GuiJ. Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation. Mol Cell Biochem. 2015; 410(1–2):207-213.

[26] WangG, LiuS, WangL, et al. Lipocalin-2 promotes endoplasmic reticulum stress and proliferation by augmenting intracellular iron in human pulmonary arterial smooth muscle cells. Int J Biol Sci. 2017; 13(2):135-144.

[27] JaberiSA, CohenA, D’SouzaC, et al. Lipocalin-2: structure, function, distribution and role in metabolic disorders. Biomed Pharmacother. 2021; 142:112002.

[28] DaoudMS, Hussain SD, Al-DaghriNM. Cardiometabolic associations of circulating Lipocalin-2 in adults with varying degrees of adiposity and insulin resistance. Arch Biochem Biophys. 2022; 717:109138.

[29] ChenC, LuoF, WuP, et al. Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China. J Cell Mol Med. 2020; 24(4):2484-2496.

[30] XieH, HanaiJ, RenJG, et al. Targeting lactate dehydrogenase—a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metab. 2014; 19(5):795-809.

[31] BabichevaA, MakinoA, YuanJX. mTOR signaling in pulmonary vascular disease: pathogenic role and therapeutic target. Int J Mol Sci. 2021; 22(4):2144.

[32] JinX, KuangY, LiL, et al. A positive feedback circuit comprising p21 and HIF-1α aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1/LDHA-mediated glycolysis. FASEB J. 2022; 36(3):e22229.

[33] WaypaGB, Schumacker PT. Roles of HIF1 and HIF2 in pulmonary hypertension: it all depends on the context. Eur Respir J. 2019; 54(6):1901929.

[34] OhS, SeoSB, KimG, Batsukh S, SonKH, ByunK. Poly-D,L-lactic acid stimulates angiogenesis and collagen synthesis in aged animal skin. Int J Mol Sci. 2023; 24(9):7986.

[35] LiS, YuJ, ZhangJ, Li X, YuJ. LSD1 interacting with HSP90 promotes skin wound healing by inducing metabolic reprogramming of hair follicle stem cells through the c-MYC/LDHA axis. FASEB J. 2023; 37(7):e23031.

[36] LinCY, WangBJ, FuYK, et al. Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism. Clin Transl Med. 2022; 12(3):e764.

[37] FangY, ShenZY, ZhanYZ, et al. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019; 10(1):3981.

[38] WangXH, JiangZH, YangHM, Zhang Y, XuLH. Hypoxia-induced FOXO4/LDHA axis modulates gastric cancer cell glycolysis and progression. Clin Transl Med. 2021; 11(1):e279.

[39] WangF, ChenL, KongD, et al. Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A/HIF-1α transcriptional complex. Hepatology. 2024; 79(3):606-623.

[40] LiY, SunXX, QianDZ, Dai MS. Molecular crosstalk between MYC and HIF in cancer. Front Cell Dev Biol. 2020; 8:590576.

[41] DongL, LiuX, WuB, et al. Mxi1-0 promotes hypoxic pulmonary hypertension via ERK/c-Myc-dependent proliferation of arterial smooth muscle cells. Front Genet. 2022; 13:810157.

[42] MiyagawaK, ShiM, ChenPI, et al. Smooth muscle contact drives endothelial regeneration by BMPR2-Notch1-mediated metabolic and epigenetic changes. Circ Res. 2019; 124(2):211-224.

[43] BianJS, ChenJ, ZhangJ, et al. ErbB3 governs endothelial dysfunction in hypoxia-induced pulmonary hypertension. Circulation. 2024.

[44] BarnesEA, ItoR, CheX, AlviraCM, CornfieldDN. Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2023; 325(6): L741-L755.

[45] PullamsettiSS, Mamazhakypov A, WeissmannN, SeegerW, SavaiR. Hypoxia-inducible factor signaling in pulmonary hypertension. J Clin Invest. 2020; 130(11):5638-5651.

[46] WangX, ZhangC, ZouN, et al. Lipocalin-2 silencing suppresses inflammation and oxidative stress of acute respiratory distress syndrome by ferroptosis via inhibition of MAPK/ERK pathway in neonatal mice. Bioengineered. 2022; 13(1):508-520.

[47] XuWX, ZhangJ, HuaYT, Yang SJ, WangDD, TangJH. An integrative Pan-cancer analysis revealing LCN2 as an oncogenic immune protein in tumor microenvironment. Front Oncol. 2020; 10:605097.

[48] GuptaU, GhoshS, WallaceCT, et al. Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD. Autophagy. 2023; 19(1):92-111.

[49] JungBK, ParkY, YoonB, et al. Reduced secretion of LCN2 (lipocalin 2) from reactive astrocytes through autophagic and proteasomal regulation alleviates inflammatory stress and neuronal damage. Autophagy. 2023; 1-22:2296-2317.

[50] WenY, ChenX, FengH, et al. Kdm6a deficiency in microglia/macrophages epigenetically silences Lcn2 expression and reduces photoreceptor dysfunction in diabetic retinopathy. Metabolism. 2022; 136:155293.

[51] WangJ, WangC, XuP, et al. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Theranostics. 2021; 11(11):5387-5403.

[52] HaoP, ZhangJ, FangS, et al. Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway. Hum Cell. 2022; 35(5):1475-1486.

[53] XiaoX, YeohBS, Vijay-KumarM. Lipocalin 2: An emerging player in iron homeostasis and inflammation. Annu Rev Nutr. 2017; 37:103-130.

[54] SanmarcoLM, RoneJM, PolonioCM, et al. Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells. Nature. 2023; 620(7975):881-889.

[55] HuK, DingY, ZhuH, et al. Glutamate dehydrogenase1 supports HIF-1α stability to promote colorectal tumorigenesis under hypoxia. EMBO J. 2023; 42(12):e112675.

[56] YammineL, Zablocki A, BaronW, TerziF, Gallazzini M. Lipocalin-2 regulates epidermal growth factor receptor intracellular trafficking. Cell Rep. 2019; 29(7):2067-2077.e6.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.